Sorl1 as an Alzheimer’s Disease Predisposition Gene?

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressively disabling impairments in memory, cognition, and non-cognitive behavioural symptoms. Sporadic AD is multifactorial and genetically complex. While several monogenic mutations cause early-onset AD and gene alleles h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-degenerative diseases 2008-01, Vol.5 (2), p.60-64
Hauptverfasser: Webster, Jennifer A., Myers, Amanda J., Pearson, John V., Craig, David W., Hu-Lince, Diane, Coon, Keith D., Zismann, Victoria L., Beach, Thomas, Leung, Doris, Bryden, Leslie, Halperin, Rebecca F., Marlowe, Lauren, Kaleem, Mona, Huentelman, Matthew J., Joshipura, Keta, Walker, Douglas, Heward, Christopher B., Ravid, Rivka, Rogers, Joseph, Papassotiropoulos, Andreas, Hardy, John, Reiman, Eric M., Stephan, Dietrich A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressively disabling impairments in memory, cognition, and non-cognitive behavioural symptoms. Sporadic AD is multifactorial and genetically complex. While several monogenic mutations cause early-onset AD and gene alleles have been suggested as AD susceptibility factors, the only extensively validated susceptibility gene for late-onset AD is the apolipoprotein E (APOE) Ε4 allele. Alleles of the APOE gene do not account for all of the genetic load calculated to be responsible for AD predisposition. Recently, polymorphisms across the neuronal sortilin-related receptor (SORL1) gene were shown to be significantly associated with AD in several cohorts. Here we present the results of our large case-control whole-genome scan at over 500,000 polymorphisms which presents weak evidence for association and potentially narrows the association interval.
ISSN:1660-2854
1660-2862
DOI:10.1159/000110789